Revolution Medicines (RVMD) Financials: Revenue & Earnings

RVMD price $186.77 +0.55 +0.30%

Ticker
RVMD
Price
$186.77
Change
+0.55 +0.30%
Market cap ?
$40.03B
P/E ?
-20.76
Forward P/E ?
32.08
Dividend yield ?
0.00%
Beta ?
1.40
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
60
Value
43
Quality
46
Growth
90

Stocklytics score rationale: value 43, quality 46, growth 90.

Financials

201720182019202020212022202320242025
020165000500410004298300029390000353800001158000000

Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The…

Fair value

RVMD fair value $228.66. Price $186.77. Price is 18% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare RVMD

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-2.35—25.58M
2026-08-05-3.06-2.04—1.77M
2026-05-06-2.29-1.84—2.42M
2026-02-25-1.86-1.58—3.68M
2025-11-05-1.61-1.42—1.69M
2025-08-06-1.31-1.14—27.53M
2025-05-07-1.13-1.12—1.20M
2025-02-26-1.12-1.01—375.00K
2024-11-06-0.94-0.89—346.15K
2024-08-07-0.81-0.77—807.69K
2024-05-08-0.70-0.75—1.37M
2024-02-26-1.14-0.88742.00K666.67K
2023-11-06-0.99-1.01—750.00K
2023-08-08-0.92-0.823.82M1.56M
2023-05-08-0.72-0.817.01M3.39M
2023-02-27-0.63-0.8215.33M7.80M
2022-11-07-0.87-0.843.36M6.34M
2022-08-09-0.82-0.859.12M7.02M
2022-05-09-0.78-0.777.58M8.58M
2022-02-28-0.71-0.649.46M8.99M
2021-11-10-0.72-0.631.10M923.42K
2021-08-11-0.60-0.568.70M8.70M
2021-05-10-0.53-0.5210.13M9.94M
2021-03-02-0.52-0.388.75M16.78M
2020-11-12-0.42-0.3912.66M11.69M
2020-08-10-0.46-0.3610.03M7.85M
2020-05-14-0.74-0.3311.55M10.39M
2020-03-30-6.52-0.4112.09M—
2020-02-13-0.35—12.51M—
2019-06-30-0.28—12.28M—
2019-03-31-0.28—13.17M—
2018-12-31-0.31—10.35M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-29Sandler Alan B.Sell6.00K$58.84353.04K
2026-09-29Sandler Alan B.Buy6.00K$58.84353.04K
2026-09-29Sandler Alan B.Sell2.20K$200.82441.80K
2026-09-29Sandler Alan B.Sell1.61K$201.72324.57K
2026-09-29Sandler Alan B.Sell1.00K$202.81202.81K
2026-09-29Sandler Alan B.Sell1.20K$203.91244.48K
2026-09-29Sandler Alan B.Sell301$204.7261.62K
2026-09-25Cislini JeffSell765$207.32158.60K
2026-09-25Mancini AnthonySell3.12K$33.62104.93K
2026-09-25Mancini AnthonyBuy3.12K$33.62104.93K
2026-09-25Mancini AnthonySell3.12K$200.54625.89K
2026-09-24Mancini AnthonySell587$200.00117.40K
2026-09-22ANDERSON ELIZABETH MBuy5.07K$1.125.68K
2026-09-22ANDERSON ELIZABETH MSell910$191.85174.59K
2026-09-22ANDERSON ELIZABETH MSell4.99K$192.54959.81K
2026-09-22ANDERSON ELIZABETH MSell2.65K$193.44512.23K
2026-09-22ANDERSON ELIZABETH MSell1.50K$194.59291.88K
2026-09-22ANDERSON ELIZABETH MSell100$195.1519.52K
2026-09-22ANDERSON ELIZABETH MSell5.07K$1.125.68K
2026-09-18Mancini AnthonySell1.76K$196.94347.40K
2026-09-16Sandler Alan B.Sell5$194.96975
2026-09-16Sandler Alan B.Sell336$199.3066.97K
2026-09-16Mancini AnthonySell27$195.055.27K
2026-09-16Mancini AnthonySell1.75K$199.30348.18K
2026-09-16Kelsey Stephen MichaelSell85$195.0116.58K
2026-09-16Kelsey Stephen MichaelSell5.48K$199.301.09M
2026-09-16Horn Margaret ASell76$195.0114.82K
2026-09-16Horn Margaret ASell4.89K$199.30974.79K
2026-09-16GOLDSMITH MARK ASell213$195.0141.54K
2026-09-16GOLDSMITH MARK ASell13.78K$199.302.75M
2026-09-16Cislini JeffSell52$195.0110.14K
2026-09-16Cislini JeffSell3.31K$199.30660.49K
2026-09-16Anders JackSell61$195.0011.89K
2026-09-16Anders JackSell3.99K$199.30795.62K
2026-09-11Kelsey Stephen MichaelBuy40.03K$40.741.63M
2026-09-11Kelsey Stephen MichaelSell800$198.55158.84K
2026-09-11Kelsey Stephen MichaelSell11.83K$200.112.37M
2026-09-11Kelsey Stephen MichaelSell13.37K$200.782.68M
2026-09-11Kelsey Stephen MichaelBuy52.50K$42.452.23M
2026-09-11Kelsey Stephen MichaelSell21.45K$201.754.33M
2026-09-11Kelsey Stephen MichaelSell18.87K$203.063.83M
2026-09-11Kelsey Stephen MichaelSell17.95K$203.873.66M
2026-09-11Kelsey Stephen MichaelSell5.00K$204.841.02M
2026-09-11Kelsey Stephen MichaelSell3.27K$205.81672.99K
2026-09-11Kelsey Stephen MichaelSell40.03K$40.741.63M
2026-09-11Kelsey Stephen MichaelSell52.50K$42.452.23M
2026-09-10Mancini AnthonySell9.36K$33.62314.78K
2026-09-10Mancini AnthonyBuy9.36K$33.62314.78K
2026-09-10Mancini AnthonySell6.02K$203.281.22M
2026-09-10Mancini AnthonySell5.53K$204.141.13M
2026-09-10Mancini AnthonySell2.42K$205.05496.22K
2026-09-10Mancini AnthonySell1.18K$206.10242.99K
2026-09-10Mancini AnthonySell300$207.1762.15K
2026-09-08Kim Lorence H.Sell706$206.60145.86K
2026-09-08Kim Lorence H.Sell999$207.33207.12K
2026-09-08Kim Lorence H.Sell3.59K$208.55748.08K
2026-09-08Kim Lorence H.Sell2.85K$209.56597.87K
2026-09-08Kim Lorence H.Sell4.73K$210.50995.68K
2026-09-08Kim Lorence H.Sell3.84K$211.36812.46K
2026-09-08Kim Lorence H.Sell371$212.2778.75K
2026-08-31Kim Lorence H.Sell300$200.5660.17K
2026-08-31Kim Lorence H.Sell6.60K$201.471.33M
2026-08-31Kim Lorence H.Sell12.92K$202.482.62M
2026-08-31Kim Lorence H.Sell26.16K$203.555.32M
2026-08-31Kim Lorence H.Sell7.27K$204.351.49M
2026-08-31Kim Lorence H.Sell2.13K$205.19436.64K
2026-08-31Kim Lorence H.Sell625$206.15128.85K
2026-08-21Cislini JeffBuy26.60K$21.61574.83K
2026-08-21Cislini JeffSell3.40K$207.24704.60K
2026-08-21Cislini JeffSell17.32K$208.373.61M
2026-08-21Cislini JeffBuy29.68K$18.56550.86K
2026-08-21Cislini JeffSell25.82K$209.255.40M
2026-08-21Cislini JeffSell2.54K$210.26534.07K
2026-08-21Cislini JeffSell4.50K$211.34951.04K
2026-08-21Cislini JeffSell3.31K$212.06702.76K
2026-08-21Cislini JeffSell26.60K$21.61574.83K
2026-08-21Cislini JeffSell29.68K$18.56550.86K
2026-08-21GOLDSMITH MARK ABuy80.00K$4.73378.40K
2026-08-21GOLDSMITH MARK ASell80.00K$4.73378.40K
2026-08-21GOLDSMITH MARK ASell5.13K$207.231.06M
2026-08-21GOLDSMITH MARK ASell24.92K$208.375.19M
2026-08-21GOLDSMITH MARK ASell35.94K$209.267.52M
2026-08-21GOLDSMITH MARK ASell3.81K$210.25801.67K
2026-08-21GOLDSMITH MARK ASell6.58K$211.331.39M
2026-08-21GOLDSMITH MARK ASell3.62K$212.08767.93K
2026-08-21GOLDSMITH MARK ASell177$207.2536.68K
2026-08-21GOLDSMITH MARK ASell190$207.2539.38K
2026-08-21GOLDSMITH MARK ASell937$208.36195.23K
2026-08-21GOLDSMITH MARK ASell951$208.36198.15K
2026-08-21GOLDSMITH MARK ASell1.35K$209.28282.74K
2026-08-21GOLDSMITH MARK ASell1.41K$209.27294.02K
2026-08-21GOLDSMITH MARK ASell136$210.4028.61K
2026-08-21GOLDSMITH MARK ASell126$210.4026.51K
2026-08-21GOLDSMITH MARK ASell245$211.4751.81K
2026-08-21GOLDSMITH MARK ASell229$211.4648.43K
2026-08-21GOLDSMITH MARK ASell127$212.0626.93K
2026-08-21GOLDSMITH MARK ASell126$212.0626.72K
2026-06-29Patel SushilBuy2.96K$37.54110.93K
2026-06-29Patel SushilSell300$183.1754.95K
2026-06-29Patel SushilSell900$184.59166.13K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 738, holders +179 vs prior quarter. Ownership 102.39%.

HolderSharesChangeChange %Value
BLACKROCK, INC.13.70M2.48M+22.15%2.56B
FARALLON CAPITAL MANAGEMENT, L.L.C.13.55M-54.00K-0.40%2.54B
FMR LLC12.20M3.74M+44.14%2.28B
BAKER BROS. ADVISORS LP11.44M1.89M+19.76%2.14B
DARWIN GLOBAL MANAGEMENT, LTD.10.63M8.42M+380.77%2.05B
JUPITER TOPCO LLC10.74M10.74MNew2.01B
VANGUARD CAPITAL MANAGEMENT LLC9.09M726.38K+8.69%1.70B
VANGUARD PORTFOLIO MANAGEMENT LLC8.29M792.23K+10.56%1.55B
NEXTECH INVEST LTD.7.60M00.00%1.42B
PARADIGM BIOCAPITAL ADVISORS LP6.36M-294.38K-4.42%1.19B
UBS GROUP AG5.45M1.06M+24.20%1.02B
STATE STREET CORP4.90M494.39K+11.23%917.12M
CAPITAL WORLD INVESTORS4.01M4.01MNew750.66M
GEODE CAPITAL MANAGEMENT, LLC3.94M604.53K+18.11%736.81M
WELLINGTON MANAGEMENT GROUP LLP3.84M-2.18M-36.24%719.79M
JPMORGAN CHASE & CO3.30M3.00M+994.27%636.93M
BVF INC/IL2.97M108.38K+3.79%555.32M
ALPHABET INC.2.95M-345.91K-10.51%551.84M
CASDIN CAPITAL, LLC2.58M00.00%482.68M
DEERFIELD MANAGEMENT COMPANY, L.P.2.39M95.00K+4.14%447.97M
PRICE T ROWE ASSOCIATES INC /MD/2.39M-841.91K-26.05%447.66M
AVORO CAPITAL ADVISORS LLC2.30M-47.44K-2.02%430.18M
NORGES BANK2.16M2.16MNew404.05M
GOLDMAN SACHS GROUP INC2.13M-52.40K-2.40%399.49M
NEARWATER CAPITAL MARKETS, LTD2.10M1.42M+209.29%392.73M

Earnings and financials

Revolution Medicines, Inc. (RVMD) trades at $186.77, with a market cap of $40.03B and a trailing P/E of -20.76. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
020165000500410004298300029390000353800001158000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Revolution Medicines (RVMD) Financials: Revenue & Earnings

RVMD$186.77+0.55 +0.30%

$40.03B

Market Cap

-20.76

P/E

32.08

Forward P/E

60

Score

Price History